Sarfaraz Khan Niazi (Urdu: سرفراز خان نیازی; born 1949) is an Indian-born academic with an expertise in pharmaceutical sciences.

From 1988 to 1996, he worked for Abbott Laboratories as its director of technical affairs;[4] at the same time, he was a professor of pharmacology at the Aga Khan University Hospital in Karachi.

[4] In 1997, he established his own consulting business, known as Pharmaceutical Scientist, Inc.[5][4] In 2003, he founded Therapeutic Proteins, Inc. to develop biosimilar versions of biopharmaceuticals, such as filgrastim, erythropoietin, interferon, Pegfilgrastim, adalimumab, and other monoclonal antibodies.

[citation needed] In 2002, Niazi published the first complete translation[6] of the ghazals of Mirza Asadullah Baig Khan, known as "Ghalib"[7] and another in 2009.

On 14 August 2012, the Government of Pakistan announced that President Asif Ali Zardari would be awarded the Sitara-i-Imtiaz in Engineering Science to Sarfaraz.